Ruth
Lagarde

Ruth Lagarde is a clinical trial operations professional with over five years of progressive experience leading global patient recruitment strategy and enrollment delivery across multi-phase studies at Syneos Health, one of the world's top-five contract research organisations.

Her work spans the full trial lifecycle, from study start-up and vendor onboarding through site activation, enrollment monitoring, and close-out. She currently manages a portfolio of concurrent Phase II and III studies across more than 25 global sites on five continents, overseeing multi-million dollar recruitment budgets, international vendor ecosystems, and cross-functional delivery teams spanning EU, North America, South America, Asia, and Africa.

Ruth brings particular depth in enrollment forecasting and real-time risk mitigation, building centralised tracking models that allow her teams to act before issues surface rather than after they appear in milestone reports. Her approach to site management is relationship-first: she trains and supports CRAs, engages sites as strategic partners, and builds the kind of sponsor confidence that comes from consistent, transparent delivery.

She is a dedicated advocate for clinical trial diversity and inclusive enrollment, designing recruitment strategies that reflect the epidemiology of each indication from protocol, not as a regulatory afterthought. This expertise is directly aligned with current FDA and ICH guidance on diverse representation in clinical research.

Ruth holds an MS in Applied Clinical Research with a medical device specialisation from St. Cloud State University, completed with a 3.94 GPA while simultaneously working in clinical operations at Syneos Health. She is bilingual in English and French, providing direct operational value across European site networks, multilingual regulatory submissions, and international sponsor communications.